These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16784838)

  • 21. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J
    Curr Opin Investig Drugs; 2006 Jan; 7(1):54-9. PubMed ID: 16425672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies.
    Verheyen A; Peeraer E; Lambrechts D; Poesen K; Carmeliet P; Shibuya M; Pintelon I; Timmermans JP; Nuydens R; Meert T
    Neuroscience; 2013 Aug; 244():77-89. PubMed ID: 23583762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
    Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI
    Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuronal cells derived from induced pluripotent stem cells to model motoneuron diseases].
    Bohl D
    Biol Aujourdhui; 2016; 210(1):27-36. PubMed ID: 27286578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
    Suzuki M; Svendsen CN
    Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.
    Oosthuyse B; Moons L; Storkebaum E; Beck H; Nuyens D; Brusselmans K; Van Dorpe J; Hellings P; Gorselink M; Heymans S; Theilmeier G; Dewerchin M; Laudenbach V; Vermylen P; Raat H; Acker T; Vleminckx V; Van Den Bosch L; Cashman N; Fujisawa H; Drost MR; Sciot R; Bruyninckx F; Hicklin DJ; Ince C; Gressens P; Lupu F; Plate KH; Robberecht W; Herbert JM; Collen D; Carmeliet P
    Nat Genet; 2001 Jun; 28(2):131-8. PubMed ID: 11381259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.
    Kliem MA; Heeke BL; Franz CK; Radovitskiy I; Raore B; Barrow E; Snyder BR; Federici T; Kaye Spratt S; Boulis NM
    Amyotroph Lateral Scler; 2011 Sep; 12(5):331-9. PubMed ID: 21864053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for amyotrophic lateral sclerosis.
    Federici T; Boulis NM
    Neurobiol Dis; 2012 Nov; 48(2):236-42. PubMed ID: 21889591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gene Therapies in Motor Neuron Diseases ALS and SMA].
    Günther R
    Fortschr Neurol Psychiatr; 2023 Apr; 91(4):153-163. PubMed ID: 36822211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model.
    Kim KS; Lee HJ; An J; Kim YB; Ra JC; Lim I; Kim SU
    Cell Transplant; 2014; 23(12):1585-97. PubMed ID: 24070071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
    Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
    Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor gene therapy improves nerve regeneration in a model of obstetric brachial plexus palsy.
    Hillenbrand M; Holzbach T; Matiasek K; Schlegel J; Giunta RE
    Neurol Res; 2015 Mar; 37(3):197-203. PubMed ID: 25213596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.
    Zheng C; Nennesmo I; Fadeel B; Henter JI
    Ann Neurol; 2004 Oct; 56(4):564-7. PubMed ID: 15389897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
    Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
    Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential.
    Zachary I
    Neurosignals; 2005; 14(5):207-21. PubMed ID: 16301836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.